Avicanna Announces Resignation of Dr. Amza Ali as Chief Medical Officer, Effective January 28, 2021
January 21, 2021 at 07:30 am EST
Avicanna Inc. announced the resignation of Dr. Amza Ali from his role of Chief Medical Officer so that he may focus more on his medical, academic, and other research pursuits and to dedicate more time to his family. Dr. Ali’s resignation will be effective January 28, 2021. Dr. Ali will continue to advise on the Company’s neurology-related projects including the recently announced epilepsy collaboration with UHN.